Scrub Care

Description

CVS Health Advanced Antimicrobial Hand Soap contains CHLORHEXIDINE GLUCONATE 2% solution, serving as an antiseptic and antimicrobial skin cleanser. This formulation is specifically designed for use by healthcare professionals and is clinically proven to effectively reduce bacteria on the skin. The product is free from parabens and phthalates, ensuring a safer option for users. It is available in an 8.5 FL OZ (250 mL) dosage form. The National Drug Code (NDC) for this product is 59779-722-75.

Uses and Indications

This drug is indicated for use as a surgical hand scrub, significantly reducing the number of microorganisms on the hands and forearms prior to surgery or patient care. Additionally, it is indicated for healthcare personnel handwashing, aiding in the reduction of bacteria that may potentially cause disease.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should adhere to the following guidelines for the proper use of the product in surgical hand scrubs and healthcare personnel handwashing.

For surgical hand scrubs, the procedure is as follows:

1. Wet hands and forearms under running water for 30 seconds.

2. Clean fingernails using a nailstick or a similar cleaner.

3. Dispense approximately 8 mL of the product and scrub for 1.5 minutes, utilizing a wet brush if desired. Special attention should be given to the nails, cuticles, and the skin between the fingers.

4. Rinse thoroughly under running water for 30 seconds.

5. Repeat the scrubbing process for an additional 1.5 minutes with another 8 mL of the product, followed by a thorough rinse under running water for 30 seconds.

6. Dry hands and forearms thoroughly.

For healthcare personnel handwashing, the following steps should be followed:

1. Wet hands with water.

2. Dispense approximately 5 mL of the product into cupped hands.

3. Wash hands vigorously for about 15 seconds.

4. Rinse hands thoroughly and dry completely.

These procedures are essential for maintaining proper hygiene and preventing infection in clinical settings.

Contraindications

Use of this product is contraindicated in individuals with a known allergy to chlorhexidine gluconate or any other component of the formulation. Additionally, the product should not be used routinely in patients with wounds that extend beyond the superficial layers of the skin, as this may pose a risk of adverse effects.

Warnings and Precautions

For external use only. This product carries a significant risk of severe allergic reactions. Symptoms indicative of such reactions may include wheezing or difficulty breathing, shock, facial swelling, hives, and rash. In the event of an allergic reaction, it is imperative to discontinue use immediately and seek medical assistance.

This product should not be used by individuals with known allergies to chlorhexidine gluconate or any other component of the formulation.

When utilizing this product, it is crucial to avoid contact with the eyes, ears, and mouth. Exposure to these areas may result in serious and permanent eye injury or potential deafness if the solution is instilled into the middle ear through perforated eardrums. Should the solution come into contact with these sensitive areas, it is essential to rinse thoroughly and promptly with water.

Routine use of this product is not recommended for individuals with wounds that extend beyond the superficial layers of the skin.

Healthcare professionals should advise patients to discontinue use and consult a physician if any signs of irritation, sensitization, or allergic reaction occur, as these may indicate a serious underlying condition.

In the event of accidental ingestion, immediate medical attention should be sought, or contact with a Poison Control Center is advised.

Side Effects

Patients using this product may experience a range of adverse reactions, which can be categorized by seriousness and frequency.

Severe allergic reactions have been reported, which may manifest as wheezing or difficulty breathing, shock, facial swelling, hives, or rash. In the event of an allergic reaction, patients are advised to discontinue use immediately and seek medical assistance. It is important to note that individuals with a known allergy to chlorhexidine gluconate or any other ingredient in this product should not use it.

During the use of this product, patients should take precautions to avoid contact with the eyes, ears, and mouth, as exposure to these areas may lead to serious and permanent eye injury or potential deafness if the solution is instilled in the middle ear through perforated eardrums. Should the solution come into contact with these sensitive areas, it is crucial to rinse thoroughly with water.

Patients are also advised to stop using the product and consult a healthcare professional if they experience irritation, sensitization, or any signs of an allergic reaction, as these may indicate a serious condition. Additionally, the product should not be used routinely on wounds that extend beyond the superficial layers of the skin.

Drug Interactions

Chlorhexidine gluconate skin cleansers may lead to staining when used concurrently with chlorine-releasing products. It is advisable to avoid the simultaneous use of these agents to prevent discoloration of the skin or surfaces.

No specific drug or laboratory test interactions have been identified in the available data. Therefore, routine monitoring or dosage adjustments related to drug interactions are not necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Scrub Care (chlorhexidine gluconate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients, particularly premature infants and those under 2 months of age, should be treated with caution. The use of these products in this population may lead to irritation or chemical burns. It is essential for healthcare professionals to closely monitor these patients to mitigate potential risks associated with their use.

Geriatric Use

Elderly patients should be monitored closely when using this medication, particularly those who are premature infants or infants under 2 months of age. The use of this product in these populations may lead to irritation or chemical burns. Caution is advised, and healthcare providers should consider the potential risks associated with its use in these vulnerable groups.

Pregnancy

Pregnant patients should be advised to use this product with caution, particularly in the context of premature infants or infants under 2 months of age. There is a potential risk of irritation or chemical burns associated with the use of this product in these vulnerable populations. Healthcare professionals are encouraged to weigh the benefits against the risks when considering the use of this product in pregnant patients, especially those who may be at risk of exposure to premature or very young infants.

Lactation

Lactating mothers should use this product with caution, particularly in the case of premature infants or those under 2 months of age. There is a risk that the product may cause irritation or chemical burns in breastfed infants. Therefore, careful consideration and monitoring are advised when administering this product to lactating mothers who are nursing young infants.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has identified several adverse reactions associated with the use of the product. Notably, reports of allergic reactions have been documented, including severe manifestations such as wheezing, difficulty breathing, shock, facial swelling, hives, and rash.

Additionally, instances of irritation, sensitization, or allergic reactions have been reported, which may indicate the potential for serious conditions. These events were reported voluntarily or through surveillance programs, contributing to the ongoing assessment of the product's safety profile.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is crucial to inform patients to keep the solution away from the eyes, ears, and mouth, as contact with these areas may lead to serious and permanent eye injury or potential deafness if instilled in the middle ear through perforated eardrums.

In the event that the solution comes into contact with the eyes, ears, or mouth, patients should be instructed to rinse the affected area promptly and thoroughly with water. Providers should also caution patients against routine use of the product if they have wounds that extend beyond the superficial layers of the skin.

Patients should be made aware that they must stop using the product and consult a doctor if they experience any irritation, sensitization, or allergic reactions, as these symptoms may indicate a serious condition.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It should be stored at a controlled room temperature of 20-25°C (68-77°F). Care must be taken to avoid exposure to excessive heat, as temperatures above 40°C (104°F) may compromise the integrity of the product. Proper storage conditions are essential to maintain the product's efficacy and safety.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Scrub Care, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)